Impact BioMedical, Inc. (IBO)
4.44
-0.24
(-5.13%)
USD |
NYAM |
Oct 07, 14:43
Impact BioMedical Net Income (Quarterly) : -0.70M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.70M |
| March 31, 2026 | -2.284M |
| December 31, 2025 | 5.235M |
| September 30, 2025 | -1.475M |
| June 30, 2025 | -14.35M |
| March 31, 2025 | -1.278M |
| December 31, 2024 | -27.13M |
| September 30, 2024 | 4.241M |
| June 30, 2024 | -0.884M |
| March 31, 2024 | -0.998M |
| December 31, 2023 | -1.261M |
| September 30, 2023 | -1.177M |
| June 30, 2023 | -1.121M |
| March 31, 2023 | -0.849M |
| Date | Value |
|---|---|
| December 31, 2022 | -3.537M |
| September 30, 2022 | -2.236M |
| June 30, 2022 | -0.799M |
| March 31, 2022 | -0.746M |
| December 31, 2021 | 0.055M |
| September 30, 2021 | -0.9204M |
| June 30, 2021 | -0.425M |
| March 31, 2021 | -0.5576M |
| December 31, 2020 | -0.2749M |
| September 30, 2020 | -0.1785M |
| June 30, 2020 | -0.2358M |
| March 31, 2020 | -0.1256M |
| September 30, 2019 | -0.1286M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| LENZ Therapeutics, Inc. | -31.92M |
| Enveric Biosciences, Inc. | -3.028M |
| ANI Pharmaceuticals, Inc. | 23.00M |
| Corcept Therapeutics, Inc. | 42.14M |
| Veru, Inc. | -6.988M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 0.003M |
| Total Expenses (Quarterly) | 0.702M |
| EPS Diluted (Quarterly) | -0.0818 |
| Enterprise Value | 43.22M |
| Gross Profit Margin (Quarterly) | -9.40K% |
| Profit Margin (Quarterly) | -23.33K% |
| Earnings Yield | -27.92% |
| Normalized Earnings Yield | -30.81 |